Jan 9 (Reuters) - The U.S. Environmental Protection Agency will reassess the safety of herbicide paraquat, its administrator Lee Zeldin said on Friday on X, adding that the body is requiring manufacturers to thoroughly prove that current uses are safe in real-world conditions.
Syngenta, which markets paraquat under the brand name Gramoxone, is among the herbicide's major sellers.
The Swiss-based agricultural chemical company is facing several lawsuits in the U.S., where plaintiffs allege exposure to paraquat caused them to develop Parkinson's, a degenerative brain disease that leads to loss of muscle coordination.
It has previously said there was "no credible evidence" that paraquat causes Parkinson's.
In agricultural settings, paraquat is mostly applied to soybean, corn and cotton crop fields to control invasive weeds and grasses, according to the Environmental Protection Agency.
(Reporting by Costas Pitas and Pooja Menon; Editing by Alan Barona)
LATEST POSTS
- 1
Accomplishing Balance between fun and serious activities: Procedures for a Better Life - 2Public Parks in the USA
- 3Israeli forces kill one person in series of attacks on southern Lebanon
- 4'No Kings' protests recap: More than 8 million turned out across all 50 states, organizers say
- 5Vote In favor of Your Favored Kind Of Tea
- Figure out how to Keep up with Your Dental Inserts for Long haul Achievement
- How much should a kid's birthday party cost? One mom spent $190 for pizza and ice cream at a park. Another paid $2K for a playspace and goodie bags.
- Scientists solve the mystery of the prehistoric 'Burtele Foot'
- James Webb Space Telescope discovers a lemon-shaped exoplanet unlike anything seen before: 'What the heck is this?'
- Thousands of ultra-orthodox protest in Jerusalem against conscription
- 5 Indoor Plants That Further develop Air Quality
- Key Caper d: A Survey of \Procedure and Tomfoolery Released\ Tabletop game
- The ‘Stranger Things’ finale, explained: What happens to Vecna? And why was a key character’s fate left unknown?
- Changes to CDC website spark debate over autism and vaccine misinformation
